Technical420 Site Search

The presidential election is right around the corner and cannabis stocks are poised to benefit from this event as market sentiment improves with the opening of new state markets.This November, a record number of states (at least nine) will have some type of cannabis initiative on the ballot. California, Arizona,…

Terra Tech (TRTC) reported financial results for the second quarter and the company saw significant growth from a revenue perspective on a year-over-year basis.Although we are favorable on this top-line growth, a majority of this revenue was generated by its Edible Garden subsidiary which has a very low gross margin.Cannabis…

On Friday, Health Canada announced that the Marihuana for Medical Purposes Regulations (MMPR) will be replaced by the Access to Cannabis for Medical Purposes Regulations (ACMPR). The ACMPR essentially re-added the MMAR personal plant count limit and designated grower options to the MMPR licensed producer model, which will formally begin…

Featuring executives from leading cannabis companies like Privateer Holdings, Greenwave Advisors, MassRoots, Aurora Cannabis, MJardin, Potbotics, CannaKorp, just to name a few!The Cannabis Investing Event, taking place on August 23rd, is FREE to attend and you can watch it LIVE from your office or home! Register to attend this event…

The Canadian medical cannabis industry continues to be a bright spot in the cannabis sector as its constituents are led by management teams that continue to execute on business initiatives and create value for shareholders.One the biggest developments in 2015 was the victory by Justin Trudeau and the Liberal Party…

JPMorgan…you are late.Yesterday, JPMorgan recommended Scotts Miracle-Gro (SMG) to its clients and changed its rating to Buy from Hold because it believes Scotts’ recent hydroponics business acquisitions will pay off as legal marijuana use increases.JPMorgan’s analyst said, “We view Scotts as a reasonably valued investment over a longer time frame…

Insys Therapeutics, Inc. (INSY) is up more than 3% in pre-market trading after the Nasdaq-trade cannabis company reported its financial results for the second quarter, which ended on June 30th.This report comes less than a month after Insys announced that the FDA approved Syndros, an orally administered liquid formulation of…

The cannabis sector continues to be one of the most attractive places to invest as the market continues to be negatively impacted by global growth concerns, increasing interest rates, and terror inspired attacks.Today, Goldman Sachs (GS), one of the largest banks in the world, downgraded its outlook on global equities…